In IGC instead of in other types of GC, IKZF3 amplification is related to dismal prognosis, and act as an independent prognostic indicator in IGC, irrespective of the pTNM stages being I-II or III-IV (Fig. 3A-D). Here, IKZF3 is linked to gastric cancer.